The relationship between leptin and lipids in atherosclerosis

Indian Heart Journal

Volumn 54, Issue 6, 2002, Pages 692-696

  Tamer, Lülüfer ^a   Ercan, B ^a   Unlu A ^a   Sucu, N ^a   Pekdemir, H ^a   Eskandari, G ^a   Atik, U ^a  

^a MERSIN UNIVERSITY   (Turkey)

Author keywords

Coronary artery disease; Leptin; Lipids

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LEPTIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LIPID BLOOD LEVEL; PROTEIN BLOOD LEVEL;

APOLIPOPROTEINS; ARTERIOSCLEROSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LEPTIN; LIPIDS; LIPOPROTEIN(A); MYOCARDIAL INFARCTION; RISK FACTORS;

EID: 0345118187     PISSN: 00194832     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Wallace AM. Measurement of leptin and leptin binding in human circulation. Ann Clin Biochem 2000; 37: 244-252
2. Meisel SR, Ellis M, Pariente C, Pauzner H, Liebowitz M, David D, et al. Serum leptin levels increase following acute myocardial infarction. Cardiology 2001; 95: 206-211
3. Cohen B, Novick D, Rubinstein M. Modulation of insulin activities by leptin. Science 1996; 274: 1185-1188
4. Haffner SM, Miettinen H, Mykkanen L, Karhapaa P, Rainwater DL, Laakso M. Leptin concentrations and insulin sensitivity in normoglycemic men. Int J Obes Relat Metab Disord 1997; 21: 393-399
5. Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Obesity, fat distribution and weight gain as risk factors for clinical diabetes in men. Diabetes Care 1994; 17: 961-969
6. Dattilo AM, Kris-Etherton PM. Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr 1992; 56: 320-328
7. Leyva F, Godsland IF, Ghatei M, Proudler AJ, Aldis S, Walton C, et al. Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk. Arterioscler Thromb Vasc Biol 1998; 18: 928-933
8. Haynes WG, Sivitiz WI, Morgan DA, Walsh SA, Mark AL. Sympathetic and cardiorenal actions of leptin. Hypertension 1997; 30: 619-623
9. Chu NF, Spiegelman D, Hotamisligil GS, Rifai N, Stampfer M, Rimm EB. Plasma insulin, leptin and soluble TNF receptors levels in relation to obesity-related atherogenic and thrombogenic cardiovascular disease risk factors among men. Atherosclerosis 2001; 157: 495-503
10. Bornstein SR, Uhlmann K, Haidan A, Ehrhart-Bornstein M, Scherbaum WA. Evidence for a novel peripheral action of leptin as a metabolic signal to the adrenal gland: leptin inhibits cortisol release directly. Diabetes 1997; 46: 1235-1238
11. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502
12. Saunders BD, Trapp RG. Association and prediction: basic and clinical biostatistics. 2nd ed. Prentice Hall International Inc: 1994. pp. 162-187
13. Söderberg S, Ahren B, Jansson JH, Johnson O, Hallmans G, Asplund K, et al. Leptin is associated with increased risk of myocardial infarction. J Intern Med 1999; 246: 409-418
14. Zhang Y, Proenca R, Margherita M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-432
15. Carro E, Senaris E, Considine RV, Casanueva FF, Dieguez C. Regulation of in vivo growth hormone secretion by leptin. Endocrinology 1997; 138: 2203-2206
16. Wallace AM, McMahon AD, Packard CJ, Kelly A, Shepherd J, Gaw A, et al. Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 2001; 104: 3052-3056
17. Sheu WH, Lee WJ, Chen YT. High plasma leptin concentrations in hypertensive men but not in hypertensive women. J Hypertens 1999; 17: 1289-1295
18. Fujimaki S, Kanda T, Fujita K, Tamura J, Kobayashi I. The significance of measuring plasma leptin in acute myocardial infarction. J Int Med Res 2001; 29: 108-113
19. Sudi KM, Gallistl S, Weinhandl G, Muntean W, Borkenstein MH. Relationship between plasminogen activator inhibitor-1 antigen, leptin, and fat mass in obese children and adolescents. Metabolism 2000; 49: 890-895
20. Sasaki A, Kurisu A, Ohno M, Ikeda Y. Overweight/obesity, smoking, and heavy alcohol consumption are important determinants of plasma PAI-1 levels in healthy men. Am J Med Sci 2001; 322: 19-23
21. Couillard C, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S, et al. Leptinemia is not risk factor for ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Diabetes Care 1998; 5: 782-786
22. Fantuzzi G, Faggioni R. Leptin in the regulation of immunity, inflammation and hematopoiesis. J Leukoc Biol 2000; 68: 437-446
23. Rainwater DL, Comuzzie DL, VandeBerg JL, Mahaney MC, Blangero J. Serum leptin levels are independently correlated with two measures of HDL. Atherosclerosis 1997; 132: 237-243
24. Wu DM, Shen MH, Chu NF. Relationship between plasma leptin levels and lipid profiles among school children in Taiwan - the Taipei Children Heart Study. Eur J Epidemiol 2001; 17: 911-916
25. Haluzik M, Fiedler J, Nedvidkova J, Ceska R. Serum leptin levels in patients with hyperlipidemias. Nutrition 2000; 16: 429-433
26. Haluzik M, Fiedler J, Nedvidkova J, Ceska R. Serum leptin concentrations in patients with combined hyperlipidemia: relationship to serum lipids and lipoproteins. Physiol Res 1999; 48: 363-368